SCHEMBL3851900

SCHEMBL3851900

CCC(=O)C(=O)[O-].[Na+]

nearest known ligand 0.00

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7064730 1.00 CA4 (0.47)
SCHEMBL1332396 1.00
Potassium Ion SCHEMBL3483407 0.96
SCHEMBL9342808 0.93 FFAR3 (0.41)
SCHEMBL4633014 0.93 FFAR3 (0.41)
Pyruvate SCHEMBL31434671 0.86 CA4 (0.50)
Propionic Acid SCHEMBL21798886 0.81 FFAR3 (0.56)
Propionic Acid SCHEMBL106190 0.77
Propionic Acid SCHEMBL4896693 0.77 FFAR3 (0.53)
Propionic Acid SCHEMBL29493216 0.77 FFAR3 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023288257-A2 BIOCATALYTIC COUPLING REACTIONS TOWARD REGIOSELECTIVELY ENRICHED SUBSTITUTED PYRAZINES CONAGEN INC. (US) 2023-01-19 WO claimed
CN-107602809-B High-solid-content aqueous polyurethane dispersion liquid based on aminocarboxylate and sulfamate simultaneously 温州大学 2020-05-22 CN claimed
US-9274101-B2 Methods and kits for obtaining a metabolic profile of living animal cells BIOLOG, INC. (US) 2016-03-01 US claimed
US-20060286627-A1 Methods and kits for obtaining a metabolic profile of living animal cells BIOLOG INC. (US) 2006-12-21 US claimed
US-4079180-A FROM CEPHALOSPORIN C AND AN ALPHA-KETO DERIVATIVE ASAHI KASEI KOGYO KABUSHIKI KAISHA (JA) 1978-03-14 US claimed
JP-63192396-A None JP disclosed
CN-121796371-B Application of alpha-ketobutyric acid in preparation of medicine for preventing and/or treating vascular calcification 昆明医科大学 2026-05-15 CN disclosed
US-12578296-B2 Bio-electrode, and method for manufacturing the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-03-17 US disclosed
US-20260061213-A1 METHOD AND APPARATUS FOR ONCOMAGNETIC TREATMENT THE METHODIST HOSPITAL DBA HOUSTON METHODIST HOSPITAL (US) 2026-03-05 US disclosed
EP-4684827-A2 DEVICE FOR ONCOMAGNETIC TREATMENT The Methodist Hospital (US) 2026-01-28 EP disclosed
US-12521564-B2 Method and apparatus for oncomagnetic treatment THE METHODIST HOSPITAL (US) 2026-01-13 US disclosed
US-20250352110-A1 BIO-ELECTRODE COMPOSITION, BIO-ELECTRODE, AND METHOD FOR PRODUCING BIO-ELECTRODE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-11-20 US disclosed
WO-1996040861-A1 MICROBIOLOGICAL MEDIA FOR ISOLATION AND IDENTIFICATION OF ENTERIC PATHOGENS SUCH AS E. COLI AND SALMONELLA BIOLOG, INC. (US) 1996-12-19 WO disclosed
EP-0386476-B1 Process for producing L-alanine MITSUBISHI PETROCHEMICAL CO (JP) 1994-07-13 EP disclosed
US-5155263-A Contacting 1,2-butanediol with molecular oxygen in the presence of a platinum catalyst MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1992-10-13 US disclosed
US-5116743-A Fumaric acid and ammonia, heat treatment of bacteria MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1992-05-26 US disclosed
EP-0386476-A1 Process for producing L-alanine MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1990-09-12 EP disclosed
JP-S63192396-A PRODUCTION OF L-ISOLEUCINE MITSUBISHI PETROCHEM CO LTD 1988-08-09 JP disclosed
US-4275031-A A CUVETTE WITH REAGENT EMBEDDED IN A CLEAR POLYMER COATING MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1981-06-23 US disclosed
US-4079180-A FROM CEPHALOSPORIN C AND AN ALPHA-KETO DERIVATIVE ASAHI KASEI KOGYO KABUSHIKI KAISHA (JA) 1978-03-14 US disclosed